Education
About Us
Working with TipRanks
Follow Us
Dexcom (DXCM)
NASDAQ:DXCM
DXCM Analyst Ratings
Strong Buy
16 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
DXCM Stock 12 Month Forecast
Average Price Target
$103.40
▲(48.84% Upside)
| Highest Price Target$120.00 | Average Price Target$103.40 | Lowest Price Target$82.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TD Cowen
Reiterated
03/26/25
Wells Fargo
Reiterated
03/25/25
Citi
Reiterated
03/25/25
Bank of America Securities
Reiterated
03/25/25
Leerink Partners
Reiterated
03/19/25
William Blair
Reiterated
03/10/25
BTIG
Reiterated
03/10/25
Piper Sandler
Reiterated
03/10/25
Stifel Nicolaus
Reiterated
03/09/25
Jefferies
Reiterated
03/04/25
Robert W. Baird
$104→$115
Buy
65.54%
Upside
Reiterated
02/14/25
DexCom price target raised to $115 from $104 at BairdDexCom price target raised to $115 from $104 at Baird
Barclays
$92→$90
Hold
29.55%
Upside
Reiterated
02/14/25
Barclays Sticks to Its Hold Rating for Dexcom (DXCM)
Bernstein
$89→$100
Buy
43.95%
Upside
Reiterated
02/14/25
Bernstein on DexCom (DXCM): Back on Track in 2025?; PT Raised to $100Bernstein SocGen Group analyst Lee Hambright raised the price target on DexCom (NASDAQ: DXCM) to $100.00 (from $89.00) while maintaining an Outperform rating.
Morgan Stanley
$75→$82
Hold
18.04%
Upside
Reiterated
02/14/25
Morgan Stanley Sticks to Its Hold Rating for Dexcom (DXCM)
Canaccord Genuity
$99→$103
Buy
48.27%
Upside
Reiterated
02/13/25
DexCom price target raised to $103 from $99 at CanaccordDexCom price target raised to $103 from $99 at Canaccord
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TD Cowen
Reiterated
03/26/25
Wells Fargo
Reiterated
03/25/25
Citi
Reiterated
03/25/25
Bank of America Securities
Reiterated
03/25/25
Leerink Partners
Reiterated
03/19/25
William Blair
Reiterated
03/10/25
BTIG
Reiterated
03/10/25
Piper Sandler
Reiterated
03/10/25
Stifel Nicolaus
Reiterated
03/09/25
Jefferies
Reiterated
03/04/25
Robert W. Baird
$104→$115
Buy
65.54%
Upside
Reiterated
02/14/25
DexCom price target raised to $115 from $104 at BairdDexCom price target raised to $115 from $104 at Baird
Barclays
$92→$90
Hold
29.55%
Upside
Reiterated
02/14/25
Barclays Sticks to Its Hold Rating for Dexcom (DXCM)
Bernstein
$89→$100
Buy
43.95%
Upside
Reiterated
02/14/25
Bernstein on DexCom (DXCM): Back on Track in 2025?; PT Raised to $100Bernstein SocGen Group analyst Lee Hambright raised the price target on DexCom (NASDAQ: DXCM) to $100.00 (from $89.00) while maintaining an Outperform rating.
Morgan Stanley
$75→$82
Hold
18.04%
Upside
Reiterated
02/14/25
Morgan Stanley Sticks to Its Hold Rating for Dexcom (DXCM)
Canaccord Genuity
$99→$103
Buy
48.27%
Upside
Reiterated
02/13/25
DexCom price target raised to $103 from $99 at CanaccordDexCom price target raised to $103 from $99 at Canaccord
DXCM Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
4
4
1
1
1
Buy
24
26
25
37
42
Hold
3
4
2
4
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
31
34
28
42
46
Each month's total comprises the sum of three months' worth of ratings.
DXCM Financial Forecast
DXCM Stock Forecast FAQ
What is DXCM’s average 12-month price target, according to analysts?
Based on analyst ratings, Dexcom’s 12-month average price target is $103.40.
What is DXCM’s upside potential, based on the analysts’ average price target?
Dexcom has 48.84% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is DXCM a Buy, Sell or Hold?
Dexcom has a consensus rating of Strong Buy which is based on 16 buy ratings, 2 hold ratings and 0 sell ratings.
What is Dexcom’s price target?
The average price target for Dexcom is $103.40. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $120.00 ,the lowest forecast is $82.00. The average price target represents 48.84% Increase from the current price of $69.47.
The highest analyst price target is $120.00 ,the lowest forecast is $82.00. The average price target represents 48.84% Increase from the current price of $69.47.
What do analysts say about Dexcom?
Dexcom’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Streets Analysts.
How can I buy shares of DXCM?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.